<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">344535</id>
  <title nil="true"/>
  <common-name>4-[2-(4,5-diphenyl-1-pyridin-2-ylimidazol-2-yl)sulfanylethyl]morpholine</common-name>
  <description>4-[2-(4,5-diphenyl-1-pyridin-2-ylimidazol-2-yl)sulfanylethyl]morpholine is a chemical compound with the formula C26H26N4OS. It has an average molecular weight of 442.60 g/mol.</description>
  <cas>60739-19-7</cas>
  <pubchem-id>3045449</pubchem-id>
  <chemical-formula>C26H26N4OS</chemical-formula>
  <weight>442.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T06:31:06Z</created-at>
  <updated-at type="dateTime">2026-08-31T06:31:06Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1COCCN1CCSC2=NC(=C(N2C3=CC=CC=N3)C4=CC=CC=C4)C5=CC=CC=C5</moldb-smiles>
  <moldb-formula>C26H26N4OS</moldb-formula>
  <moldb-inchi>InChI=1S/C26H26N4OS/c1-3-9-21(10-4-1)24-25(22-11-5-2-6-12-22)30(23-13-7-8-14-27-23)26(28-24)32-20-17-29-15-18-31-19-16-29/h1-14H,15-20H2</moldb-inchi>
  <moldb-inchikey>CUMRACWRYUEVOT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">442.1827326</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM340428</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[2-(4,5-diphenyl-1-pyridin-2-ylimidazol-2-yl)sulfanylethyl]morpholine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Imidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0294904</sync-id>
  <structure-inchikey>CUMRACWRYUEVOT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>80000000080000000000000000000000000000000000000000004000000010000401000000200400000000000000800001000000000020112000000000000000000000000000000080000000000000000000801000040000000000000000000000000001000000000002010002000000000000000000000000000000000080000000000000401080000202010000000000000000000000000000000000020000000008000004000000004008000000a010000000000000240000000010000000000000000000000000000000000000000200000000010000000000000041002040000000000000000000000000000040000000000080</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAgAAAAJAAAAIABBgBgAAAAAgIGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:43:50Z</structure-indexed-at>
</compound>
